IntraSight
Interventional applications platform
IntraSight
Interventional applications platform
The IntraSight Interventional Applications Workspace is where imaging, physiology, co-registration* and software all come together to help identify coronary and peripheral artery disease, and allow for more optimized treatment plans. IntraSight is built on a new foundational platform designed to meet the evolving needs of your lab today and tomorrow.
Best-in-class imaging, physiology and co-registration tools (with IntraSight 7 configuration)
Modern and intuitive interface minimizes learning curves and increases workflow confidence
Optimize performance with data management, remote service diagnostics and cybersecurity protection
Features
Smart, simple and seamless
Built on a new foundational platform, IntraSight provides more information through iFR/FFR and IVUS modalities in conjunction with the angiogram to provide superior patient care, deliver an outstanding user experience and optimize lab performance.
Provide superior care
IntraSight offers a comprehensive suite of clinically proven modalities to simplify complex interventions, increase the speed of routine procedures, reduce the cost of care and may help improve patient outcomes.
Designed to meet the evolving needs of lab
IntraSight is built on a foundational platform capable of quickly adding new innovations to your lab, thus ensuring you always have our latest technologies to treat your patients.
Specifications
- Power requirements
- System input
- 100, 120v, 220, 240VAC, 50/60Hz, 1000Va
- Monitor
- 100V – 240V 50/60Hz, 39W
- Workstation
- 100 – 240V, 50/60Hz, 825VA
- Dimensions
- Workstation
- H=17", W=10", D=16.5"
- Monitor
- H=15"-19", W=15.8", D=9.7"
- Control pad (optional)
- H=2.75"-19", W=10.5", D=8.3"
- Connection box
- H=9.95", W=2.95",D=7.75"
- Touch screen module with articulating tableside mount
- H=7”, W=11.9”, D=9” Arm extends to a depth of 16.5” / 20” above the bedrail
- Control room controller
- H=5", W=15", D=10"
- Processing and data storage
- Processor
- 1 CPU with 2.3GHz (Max turbo freq. of 3.2GHz) 12 core total, 2400 MHz BUS
- Hard drive capacity
- 1TB SSD SATA
- DICOM services supported
- DICOM worklist management, DICOM store
- Memory
- 32GB SD RAM
- Digital archiving capacity
- Local, DVD, DICOM Network (including Worklist management, DICOM Store)
- Ordering Information
- IntraSight 7 configuration
- IntraSight07
- IntraSight 5 configuration
- IntraSight05
Recommended products
- The SyncVision precision guidance system is suitable with IntraSight and Core Integrated interventional platforms and streamlines lesion assessment, simplifies vessel sizing and enables precise therapy delivery all while integrating seamlessly in daily workflows in interventional suites of choice.
- The Eagle Eye Platinum digital IVUS catheter is the #1 choice of physicians for intravascular imaging (in the US).* As a unique plug-and-play intravascular imaging catheter it is designed for ease of use and deliverability. Features include a soft tapered tip, GlyDx hydrophilic coating for increased lubricity, a long, rapid exchange lumen for improved pushability, three radiopaque markers, and compatibility with SyncVision for co-registration with angiography.
- The Eagle Eye Platinum ST digital IVUS catheter offers a 2.5 mm tip-to-imaging distance designed to assess more of the vessel than standard catheters by providing a closer visualization of highly stenosed lesions and distal anatomy. The short tip catheter fits through all 5F guides and has all features of our top-selling Eagle Eye Platinum model, including plug-and-play simplicity, three radiopaque markers, GlyDx hydrophilic coating, and SyncVision compatibility.*
Disclaimer
1. Davies JE, et al., Use of the Instantaneous Wave-free Ration or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.
2. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
3. Witzen B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470.
* Co-registration tools available within IntraSight 7 configuration via SyncVision
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device
Philips reserves the right to change product specifications without prior notification.
©2025 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners.